SHENYANG, China, Sept. 15 3SBio Inc. (Nasdaq:SSRX), a leading China-based biotechnology company focused on researching,developing, manufacturing and marketing biopharmaceutical products, todayannounced the results of the shareholder votes at its 2008 Annual GeneralMeeting of Shareholders held on September 12, 2008 (Friday) at 10:00 a.m.(Beijing time).
At the meeting, the Company's shareholders re-elected Dr. Jing Lou, LipingXu, Bin Huang, Lawrence S. Wizel, Mingde Yu and Moujia Qi to serve as membersof the Board of Directors until the next annual meeting of shareholders totake place in 2009. They also approved the appointment of KPMG to serve asthe Company's independent registered public accountants for the year endingDecember 31, 2008.
About 3SBio Inc.3SBio Inc. is a leading, fully integrated biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, primarily in China. For more information, please visit 3SBio on theweb at www.3sbio.com. Contacts: Investor Contact: Investor Relations (US): Kevin Teo, CFO Mahmoud Siddig 3SBio Inc. Taylor Rafferty +86 24 2581 1820 +1 (212) 889-4350 Investor Relations (HK): Media Contact: Ruby Yim Jason Marshall Taylor Rafferty Taylor Rafferty +852 3196 3712 +1 (212) 889-4350
SOURCE 3SBio Inc.